Search Login Register
Methylcholanthrene
Summary
Description:
A carcinogen that is often used in experimental cancer studies.
Also Known As:
20-Methylcholanthrene; 3-Methylcholanthrene; 3MC; 20 Methylcholanthrene; 3 Methylcholanthrene; Benz(j)aceanthrylene, 1,2-dihydro-3-methyl-
Networked: 1781
relevant articles (24 outcomes,
139 trials/studies)
for this Bio-Agent
Key Diseases for which Methylcholanthrene is
Relevant
-
Neoplasms (Cancer)
:
18 outcomes 67 studies in 842 results
-
Fibrosarcoma
:
6 outcomes 32 studies in 370 results
-
Sarcoma (Soft Tissue Sarcoma)
:
6 outcomes 31 studies in 458 results
-
Neoplasm Metastasis (Metastasis)
:
3 outcomes 3 studies in 45 results
-
Rhabdomyosarcoma
:
1 outcome 2 studies in 15 results
Show All >>
Drugs Related to Methylcholanthrene
-
Interleukin-2 (IL2)
-
Carcinogens
-
anthracene
-
DNA (Deoxyribonucleic Acid)
-
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
-
Phenobarbital (Luminal)
-
tumor-associated transplantation antigen (TSTA)
-
Peptides
-
Complement System Proteins (Complement)
-
9,10-Dimethyl-1,2-benzanthracene (DMBA)
Show All >>
Therapies Related to Methylcholanthrene
-
Heterologous Transplantation (Xenotransplantation)
-
Immunotherapy
-
Amputation
-
Transplantation (Transplant Recipients)
-
Oral Administration
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.